Rare diseases
Investigational molecules
Locations
Place Alexis Ricordeau, 44000 Nantes, 44000 Nantes, France
CHU Nantes in Nantes, France specialises in clinical trials of conditions such as HIV infection, Gastroenteropancreatic neuroendocrine tumour disease, Cytomegalovirus immunisation, and other specialisations. This site conducts important research.
The medical center is at the forefront of research in HIV-1 infection, focusing on innovative antiretroviral therapies. The center's research aims to evaluate the efficacy of new treatment regimens, such as the use of doravirine in combination with other antiretrovirals, to improve virologic outcomes in treatment-naïve individuals.
By conducting comprehensive clinical trials, the center contributes significantly to the understanding and management of HIV-1, offering hope for improved patient outcomes and quality of life.
Specializing in Small Cell Lung Cancer, the medical center is dedicated to advancing treatment options for this aggressive form of cancer. The research focuses on comparing novel therapeutic agents, such as I-DXd, with traditional chemotherapy to enhance objective response rates and overall survival in patients with relapsed SCLC.
Through rigorous clinical trials, the center aims to redefine treatment paradigms and improve prognoses for patients battling SCLC, contributing to the global fight against lung cancer.
Clinical trials currently enrolling participants at this site.
FranceFranceFranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
